InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (9 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
9
T+90 hit rate
100%
T+90 mean return
+18.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Epperly Melissa B, Chief Financial Officer. Director active across 2 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 32 reports have been logged. Breakdown: 1 buy · 9 sells. Total volume traded: €1.9m. History available since 3 May 2021. The latest transaction was disclosed on 17 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Epperly Melissa B,
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
543 shares0Common SharesSEC:0001140361-26-029192:0
670 shares0Common SharesSEC:0001807359-26-000006:0
41,861 shares@ US$28.6895.8% of flowCommon SharesSEC:0001807359-26-000004:0
815 shares0Common SharesSEC:0001140361-26-002085:0
1,056 shares0Common SharesSEC:0001140361-25-038997:0
14,524 shares0Common SharesSEC:0001140361-25-034929:0
1,609 shares0Common SharesSEC:0001140361-25-026647:0
1,847 shares0Common SharesSEC:0001140361-25-014802:0
1,672 shares0Common SharesSEC:0001140361-25-002102:0
1,613 shares0Common SharesSEC:0001140361-24-044060:0
4,245 shares@ US$12.12100.0% of flowCommon SharesSEC:0001140361-24-041233:0
16,406 shares0Common SharesSEC:0001140361-24-040987:0
1,702 shares0Common SharesSEC:0001140361-24-034279:0
1,146 shares0Common SharesSEC:0001140361-24-022617:0
2,573 shares@ US$11.440.9% of flowCommon StockSEC:0001725160-24-000043:0
75,000 shares0Common StockSEC:0001725160-24-000028:0
1,207 shares0Common SharesSEC:0001140361-24-003552:0
1,226 shares0Common SharesSEC:0001140361-23-048775:0
4,594 shares@ US$19.42652.8% of flowCommon StockSEC:0001725160-23-000179:0
17,825 shares0Common SharesSEC:0001140361-23-044045:0
1,280 shares0Common SharesSEC:0001140361-23-033547:0
2,624 shares@ US$20.42441.7% of flowCommon StockSEC:0001725160-23-000035:0
101,957 shares0Common StockSEC:0001725160-23-000017:0
50,000 shares0Common StockSEC:0001725160-22-000180:0
8,094 shares@ US$48.74750.12% mcap12.7% of flowCommon StockSEC:0001725160-22-000069:0
25 of 32 declarations
About Epperly Melissa B,
Melissa B. Epperly is Directeur Financier and is linked to Roivant Sciences Ltd. and Zentalis Pharmaceuticals, Inc. Across 31 filings in total, the 31 sampled filings run from 2021-05-05 to 2026-04-21, with 58913 EUR in buys and 1797499 EUR in sells; the most frequent transaction nature is Attribution.
